Cuprizone inhibits demyelinating leukomyelitis by reducing immune responses without virus exacerbation in an infectious model of multiple sclerosis

Journal of Neuroimmunology

Volumn 244, Issue 1-2, 2012, Pages 84-93

  Herder, Vanessa ^a,c   Hansmann, Florian ^a,c   Stangel, Martin ^b,c   Schaudien, Dirk ^a   Rohn, Karl ^a   Baumgärtner, Wolfgang ^a,c   Beineke, Andreas ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

Author keywords

Cuprizone; Interleukins; Multiple sclerosis; Theiler's murine encephalomyelitis

Indexed keywords

CUPRIZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DEMYELINATING DISEASE; DEMYELINATING LEUKOMYELITIS; DISEASE EXACERBATION; FEMALE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANIMALS; CHELATING AGENTS; CUPRIZONE; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; MICE; MULTIPLE SCLEROSIS; THEILOVIRUS;

EID: 84857913608     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.01.010     Document Type: Article

References (58)

1. Baxter A.G. The origin and application of experimental autoimmune encephalomyelitis. Nat. Rev. Immunol. 2007, 7:904-912.
2. Biancotti J.C., Kumar S., de Vellis J. Activation of inflammatory response by a combination of growth factors in cuprizone-induced demyelinated brain leads to myelin repair. Neurochem. Res. 2008, 33:2615-2628.
3. Brown A., McFarlin D.E., Raine C.S. Chronologic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse. Lab. Invest. 1982, 46:171-185.
4. Carlton W.W. Response of mice to the chelating agents sodium diethyldithiocarbamate, alpha-benzoinoxime, and biscyclohexanone oxaldihydrazone. Toxicol. Appl. Pharmacol. 1966, 8:512-521.
5. Compston A., Coles A. Multiple sclerosis. Lancet 2008, 372:1502-1517.
6. Emerson M.R., Biswas S., LeVine S.M. Cuprizone and piperonyl butoxide, proposed inhibitors of T-cell function, attenuate experimental allergic encephalomyelitis in SJL mice. J. Neuroimmunol. 2001, 119:205-213.
7. Fernandez M.A., Puttur F.K., Wang Y.M., Howden W., Alexander S.I., Jones C.A. T regulatory cells contribute to the attenuated primary CD8+ and CD4+ T cell responses to herpes simplex virus type 2 in neonatal mice. J. Immunol. 2008, 180:1556-1564.
8. Fisar Z., Hroudova J., Raboch J. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers. Neuro. Endocrinol. Lett. 2010, 31:645-656.
9. Gerhauser I., Alldinger S., Baumgärtner W. Ets-1 represents a pivotal transcription factor for viral clearance, inflammation, and demyelination in a mouse model of multiple sclerosis. J. Neuroimmunol. 2007, 188:86-94.
10. Gerhauser I., Ulrich R., Alldinger S., Baumgärtner W. Induction of activator protein-1 and nuclear factor-kappaB as a prerequisite for disease development in susceptible SJL/J mice after theiler murine encephalomyelitis. J. Neuropathol. Exp. Neurol. 2007, 66:809-818.
11. Haas J., Korporal M., Balint B., Fritzsching B., Schwarz A., Wildemann B. Glatiramer acetate improves regulatory T-cell function by expansion of naive CD4(+)CD25(+)FOXP3(+)CD31(+) T-cells in patients with multiple sclerosis. J. Neuroimmunol. 2009, 216:113-117.
12. Hansenne I., Louis C., Martens H., Dorban G., Charlet-Renard C., Peterson P., Geenen V. Aire and Foxp3 expression in a particular microenvironment for T cell differentiation. Neuroimmunomodulation 2009, 16:35-44.
13. Harvey B.H., Duvenhage I., Viljoen F., Scheepers N., Malan S.F., Wegener G., Brink C.B., Petzer J.P. Role of monoamine oxidase, nitric oxide synthase and regional brain monoamines in the antidepressant-like effects of methylene blue and selected structural analogues. Biochem. Pharmacol. 2010, 80:1580-1591.
14. Herder V., Hansmann F., Stangel M., Skripuletz T., Baumgärtner W., Beineke A. Lack of cuprizone-induced demyelination in the murine spinal cord despite oligodendroglial alterations substantiates the concept of site-specific susceptibilities of the central nervous system. Neuropathol. Appl. Neurobiol. 2011, 37:676-684.
15. Johnson A.J., Upshaw J., Pavelko K.D., Rodriguez M., Pease L.R. Preservation of motor function by inhibition of CD8+ virus peptide-specific T cells in Theiler's virus infection. FASEB J. 2001, 15:2760-2762.
16. Kesterson J.W., Carlton W.W. Histopathologic and enzyme histochemical observations of the cuprizone-induced brain edema. Exp. Mol. Pathol. 1971, 15:82-96.
17. Kesterson J.W., Carlton W.W. Monoamine oxidase inhibition and the activity of other oxidative enzymes in the brains of mice fed cuprizone. Toxicol. Appl. Pharmacol. 1971, 20:386-395.
18. Kimberlin R.H., Millson G.C. The effects of cuprizone toxicity on the incubation period of scrapie in mice. J. Comp. Pathol. 1976, 86:489-496.
19. Komoly S. Experimental demyelination caused by primary oligodendrocyte dystrophy. Regional distribution of the lesions in the nervous system of mice [corrected]. Ideggyogy. Sz. 2005, 58:40-43.
20. Komoly S., Hudson L.D., Webster H.D., Bondy C.A. Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:1894-1898.
21. Kummerfeld M., Meens J., Haas L., Baumgärtner W., Beineke A. Generation and characterization of a polyclonal antibody for the detection of Theiler's murine encephalomyelitis virus by light and electron microscopy. J. Virol. Methods 2009, 160:185-188.
22. Kurtzke J.F. Epidemiologic evidence for multiple sclerosis as an infection. Clin. Microbiol. Rev. 1993, 6:382-427.
23. Lalive P.H., Neuhaus O., Benkhoucha M., Burger D., Hohlfeld R., Zamvil S.S., Weber M.S. Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action. CNS Drugs 2011, 25:401-414.
24. Lindner M., Heine S., Haastert K., Garde N., Fokuhl J., Linsmeier F., Grothe C., Baumgärtner W., Stangel M. Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination. Neuropathol. Appl. Neurobiol. 2008, 34:105-114.
25. Lipton H.L., Canto C.D. Contrasting effects of immunosuppression on Theiler's virus infection in mice. Infect. Immun. 1977, 15:903-909.
26. Mana P., Fordham S.A., Staykova M.A., Correcha M., Silva D., Willenborg D.O., Linares D. Demyelination caused by the copper chelator cuprizone halts T cell mediated autoimmune neuroinflammation. J. Neuroimmunol. 2009, 210:13-21.
27. Matsushima G.K., Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 2001, 11:107-116.
28. Miller S.D., Vanderlugt C.L., Begolka W.S., Pao W., Yauch R.L., Neville K.L., Katz-Levy Y., Carrizosa A., Kim B.S. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 1997, 3:1133-1136.
29. Miller A., Shapiro S., Gershtein R., Kinarty A., Rawashdeh H., Honigman S., Lahat N. Treatment of multiple sclerosis with copolymer-1 (Copaxone): implicating mechanisms of Th1 to Th2/Th3 immune-deviation. J. Neuroimmunol. 1998, 92:113-121.
30. Murray P.D., McGavern D.B., Lin X., Njenga M.K., Leibowitz J., Pease L.R., Rodriguez M. Perforin-dependent neurologic injury in a viral model of multiple sclerosis. J. Neurosci. 1998, 18:7306-7314.
31. Mutlu L., Brandt C., Kwidzinski E., Sawitzki B., Gimsa U., Mahlo J., Aktas O., Nitsch R., van Zwam M., Laman J.D., Bechmann I. Tolerogenic effect of fiber tract injury: reduced EAE severity following entorhinal cortex lesion. Exp. Brain Res. 2007, 178:542-553.
32. Naoi M., Maruyama W. Monoamine oxidase inhibitors as neuroprotective agents in age-dependent neurodegenerative disorders. Curr. Pharm. Des. 2010, 16:2799-2817.
33. Navarrete-Talloni M.J., Kalkuhl A., Deschl U., Ulrich R., Kummerfeld M., Rohn K., Baumgärtner W., Beineke A. Transient peripheral immune response and central nervous system leaky compartmentalization in a viral model for multiple sclerosis. Brain Pathol. 2010, 20:890-901.
34. Oleszak E.L., Chang J.R., Friedman H., Katsetos C.D., Platsoucas C.D. Theiler's virus infection: a model for multiple sclerosis. Clin. Microbiol. Rev. 2004, 17:174-207.
35. O'Rourke A.M., Wang E.Y., Salter-Cid L., Huang L., Miller A., Podar E., Gao H.F., Jones D.S., Linnik M.D. Benefit of inhibiting SSAO in relapsing experimental autoimmune encephalomyelitis. J. Neural. Transm. 2007, 114:845-849.
36. O'Rourke A.M., Wang E.Y., Miller A., Podar E.M., Scheyhing K., Huang L., Kessler C., Gao H., Ton-Nu H.T., Macdonald M.T., Jones D.S., Linnik M.D. Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity. J. Pharmacol. Exp. Ther. 2008, 324:867-875.
37. Pringproa K., Kumnok J., Ulrich R., Baumgärtner W., Wewetzer K. In vitro characterization of a murine oligodendrocyte precursor cell line (BO-1) following spontaneous immortalization. Int. J. Dev. Neurosci. 2008, 26:283-291.
38. Racke M.K., Lovett-Racke A.E. Glatiramer acetate treatment of multiple sclerosis: an immunological perspective. J. Immunol. 2011, 186:1887-1890.
39. Rivera-Quinones C., McGavern D., Schmelzer J.D., Hunter S.F., Low P.A., Rodriguez M. Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nat. Med. 1998, 4:187-193.
40. Rodriguez M., Leibowitz J.L., Lampert P.W. Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann. Neurol. 1983, 13:426-433.
41. Roussarie J.P., Ruffie C., Brahic M. The role of myelin in Theiler's virus persistence in the central nervous system. PLoS Pathog. 2007, 3:e23.
42. Salter-Cid L.M., Wang E., O'Rourke A.M., Miller A., Gao H., Huang L., Garcia A., Linnik M.D. Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase. J. Pharmacol. Exp. Ther. 2005, 315:553-562.
43. Schaudien D., Baumgärtner W., Herden C. High preservation of DNA standards diluted in 50% glycerol. Diagn. Mol. Pathol. 2007, 16:153-157.
44. Seehusen F., Baumgärtner W. Axonal pathology and loss precede demyelination and accompany chronic lesions in a spontaneously occurring animal model of multiple sclerosis. Brain Pathol. 2010, 20:551-559.
45. Skripuletz T., Lindner M., Kotsiari A., Garde N., Fokuhl J., Linsmeier F., Trebst C., Stangel M. Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am. J. Pathol. 2008, 172:1053-1061.
46. Skripuletz T., Bussmann J.H., Gudi V., Koutsoudaki P.N., Pul R., Moharregh-Khiabani D., Lindner M., Stangel M. Cerebellar cortical demyelination in the murine cuprizone model. Brain Pathol. 2010, 20:301-312.
47. Taylor L.C., Gilmore W., Matsushima G.K. SJL mice exposed to cuprizone intoxication reveal strain and gender pattern differences in demyelination. Brain Pathol. 2009, 19:467-479.
48. Thompson A.J., Toosy A.T., Ciccarelli O. Pharmacological management of symptoms in multiple sclerosis: current approaches and future directions. Lancet Neurol. 2010, 9:1182-1199.
49. Toka F.N., Suvas S., Rouse B.T. CD4+ CD25+ T cells regulate vaccine-generated primary and memory CD8+ T-cell responses against herpes simplex virus type 1. J. Virol. 2004, 78:13082-13089.
50. Tsunoda I., Fujinami R.S. Neuropathogenesis of Theiler's murine encephalomyelitis virus infection, an animal model for multiple sclerosis. J. Neuroimmune. Pharmacol. 2010, 5:355-369.
51. Ulrich R., Gerhauser I., Seeliger F., Baumgärtner W., Alldinger S. Matrix metalloproteinases and their inhibitors in the developing mouse brain and spinal cord: a reverse transcription quantitative polymerase chain reaction study. Dev. Neurosci. 2005, 27:408-418.
52. Ulrich R., Baumgärtner W., Gerhauser I., Seeliger F., Haist V., Deschl U., Alldinger S. MMP-12. MMP-3, and TIMP-1 are markedly upregulated in chronic demyelinating theiler murine encephalomyelitis. Neuropathol. Appl. Neurobiol. 2006, 65:783-793.
53. Ulrich R., Seeliger F., Kreutzer M., Germann P.G., Baumgärtner W. Limited remyelination in Theiler's murine encephalomyelitis due to insufficient oligodendroglial differentiation of nerve/glial antigen 2 (NG2)-positive putative oligodendroglial progenitor cells. Neuropathol. Appl. Neurobiol. 2008, 34:603-620.
54. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3. (RESEARCH0034).
55. Venturini G. Enzymic activities and sodium, potassium and copper concentrations in mouse brain and liver after cuprizone treatment in vivo. J. Neurochem. 1973, 21:1147-1151.
56. Welsh C.J., Steelman A.J., Mi W., Young C.R., Dean D.D., Storts R., Welsh T.H., Meagher M.W. Effects of stress on the immune response to Theiler's virus-implications for virus-induced autoimmunity. Neuroimmunomodulation 2010, 17:169-172.
57. Young E.E., Prentice T.W., Satterlee D., McCullough H., Sieve A.N., Johnson R.R., Welsh T.H., Welsh C.J., Meagher M.W. Glucocorticoid exposure alters the pathogenesis of Theiler's murine encephalomyelitis virus during acute infection. Physiol. Behav. 2008, 95:63-71.
58. Zelinskyy G., Dietze K., Sparwasser T., Dittmer U. Regulatory T cells suppress antiviral immune responses and increase viral loads during acute infection with a lymphotropic retrovirus. PLoS Pathog. 2009, 5:e1000406.